Hypertrophic cardiomyopathy is a heart disease characterized by asymmetric hypertrophy of the ventricles, which is one of the most important causes of sudden death in adolescents, with genetic heterogeneity, mainly manifested as dyspnea, chest pain and chest tightness, palpitations, etc. Usually, general treatment, drug therapy and surgical treatment can be used to improve the symptoms of the disease, and to reduce the occurrence of complications.
1. General treatment: during the onset of the disease, we need to do a good job of life care, rest as much as possible, avoid strenuous exercise. Usually need to limit physical activity, and appropriate supplementation of fluids, to prevent the phenomenon of blood volume insufficiency.
2. Drug therapy: During the disease, it is necessary to follow the doctor’s instructions and give beta-blockers and non-dihydropyridine calcium antagonists to improve the problem of cardiac insufficiency, including metoprolol succinate, bisoprolol and so on. 24-hour ambulatory electrocardiogram monitoring is required during medication administration and can be used to assess drug effects.
3. Surgery: For patients with obstructive hypertrophic cardiomyopathy, the effect of medication may be unsatisfactory, in which case surgical treatment should be considered, such as ventricular septal myocardial resection, percutaneous septal ablation, etc. The purpose of surgery is to alleviate the clinical symptoms by reducing the degree of left ventricular obstruction.
Hypertrophic cardiomyopathy has a high rate of sudden death, and it is important to cooperate with your doctor for targeted treatment after diagnosis.